EGF stimulates Pit-1 independent transcription of the human prolactin pituitary promoter in human breast cancer SK-BR-3 cells through its proximal AP-1 response element
- PMID: 15607537
- DOI: 10.1016/j.mce.2004.08.009
EGF stimulates Pit-1 independent transcription of the human prolactin pituitary promoter in human breast cancer SK-BR-3 cells through its proximal AP-1 response element
Abstract
Normal and neoplastic human mammary gland cells are targets for the proliferative action of prolactin. These cells also synthesize prolactin, thereby inducing an autocrine/paracrine proliferative loop. We present the first extensive analysis of the transcriptional regulation of the human prolactin gene (hPRL) in human mammary tumor cells, SK-BR-3. We show that the pituitary promoter is functional in these cells in the absence of the pituitary-specific factor Pit-1. Expression of exogenous Pit-1 or epidermal growth factor (EGF) treatment stimulates the transfected hPRL pituitary promoter and the endogenous hPRL expression. EGF stimulation is mediated by increased synthesis of c-fos and c-jun, resulting in AP-1 binding to the proximal hPRL pituitary promoter. This regulation involves the EGF receptor, possibly ErbB2 that is highly expressed in SK-BR-3 cells, and a PI3K/JNK pathway. The stimulation of hPRL gene transcription by EGF in mammary cells may include hPRL in a complex regulatory network controlling growth of human mammary cells.
Similar articles
-
RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells.Mol Carcinog. 1998 Aug;22(4):247-57. Mol Carcinog. 1998. PMID: 9726817
-
Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta.Cancer Res. 2003 Apr 1;63(7):1696-705. Cancer Res. 2003. PMID: 12670924
-
Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.Cancer Res. 1997 Aug 15;57(16):3444-50. Cancer Res. 1997. PMID: 9270011
-
Transcription factors in normal and neoplastic pituitary tissues.Microsc Res Tech. 1997 Oct 15;39(2):168-81. doi: 10.1002/(SICI)1097-0029(19971015)39:2<168::AID-JEMT8>3.0.CO;2-H. Microsc Res Tech. 1997. PMID: 9361268 Review.
-
From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance.IUBMB Life. 2005 Apr-May;57(4-5):283-95. doi: 10.1080/15216540500097111. IUBMB Life. 2005. PMID: 16036612 Review.
Cited by
-
What can we learn from rodents about prolactin in humans?Endocr Rev. 2008 Feb;29(1):1-41. doi: 10.1210/er.2007-0017. Epub 2007 Dec 5. Endocr Rev. 2008. PMID: 18057139 Free PMC article. Review.
-
The Pit-1/Pou1f1 transcription factor regulates and correlates with prolactin expression in human breast cell lines and tumors.Endocr Relat Cancer. 2010 Jan 29;17(1):73-85. doi: 10.1677/ERC-09-0100. Print 2010 Mar. Endocr Relat Cancer. 2010. PMID: 19808898 Free PMC article.
-
Rational design of competitive prolactin/growth hormone receptor antagonists.J Mammary Gland Biol Neoplasia. 2008 Mar;13(1):105-17. doi: 10.1007/s10911-008-9066-8. Epub 2008 Jan 25. J Mammary Gland Biol Neoplasia. 2008. PMID: 18219565 Review.
-
Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells.J Cell Physiol. 2008 Nov;217(2):377-87. doi: 10.1002/jcp.21507. J Cell Physiol. 2008. PMID: 18615585 Free PMC article.
-
The prolactin gene: a paradigm of tissue-specific gene regulation with complex temporal transcription dynamics.J Neuroendocrinol. 2012 Jul;24(7):977-90. doi: 10.1111/j.1365-2826.2012.02310.x. J Neuroendocrinol. 2012. PMID: 22420298 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous